Stayble Therapeutics AB (publ) (FRA:4K4)

Germany flag Germany · Delayed Price · Currency is EUR
0.0174
+0.0006 (3.57%)
At close: Nov 28, 2025
-61.93%
Market Cap1.17M
Revenue (ttm)n/a
Net Income (ttm)-761.30K
Shares Outn/a
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0170
Previous Close0.0168
Day's Range0.0168 - 0.0174
52-Week Range0.0127 - 0.0528
Betan/a
RSI49.00
Earnings DateNov 20, 2025

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4K4
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.